"Designing Growth Strategies is in our DNA"

Human Platelet Lysate Market Size, Share & Industry Analysis, By Type (Heparin-based Human Platelet Lysate, Heparin-free Human Platelet Lysate, Others (Fibrinogen Depleted, etc.)), By Application (Research, Therapeutic), By End-User (Pharmaceutical and biotechnology companies, Academic & Research Institutes, Others)and Regional Forecast, 2021-2028

Region : Global | Report ID: FBI102505 | Status : Ongoing

 

KEY MARKET INSIGHTS

Human platelet lysate (HPL) is a cell culture growth supplement derived from the human donor platelets after thawing and freezing. HPL products are standardized and safe cell culture supplements that ensure high cell performance and reproducible results. They contain abundant platelet-derived growth factors and cytokines, which stimulate cellular proliferation to maintain differential potential. It also serves as an alternative to Fetal Bovine Serum (FBL) in cell and tissue culture. Increased applications of human platelet lysate in cell culture, rising acceptance of HPL due to its various advantages, growing opposition of animal-derived blood products, an increased number of mergers and acquisitions among key players to expand their product portfolio in HPL are some of the factors that are expected to fuel the growth of market during the forecast period. For instance, in May 2018, PL BioScience GmbH and Biogelx collaborated intending to enhance their current human platelet lysate based nutrient matrix and expand the range of PL Bioscience’s stem cell platform.


Key Market Driver -

Rising applications of human platelet lysate, growing investment in research and development of Human Platelet Lysate products

Key Market Restraint -

High costs and increased risk of transmission of infectious communicable diseases


Rising application of human platelet lysates in cell culture, growing investment in research and development of human platelet lysates, and increased number of mergers and acquisitions among key players to expand their product portfolio in HPL are some of the factors that are driving the market growth.


However, high costs and increased risk of transmission of infectious communicable diseases are likely to decline the growth of the human platelet lysate market.


Market Segmentation:


By type, the market can be segmented into heparin-based human platelet lysate, heparin-free human platelet lysate, and others (fibrinogen depleted, etc.). By application, the market can be segmented into research and therapeutic. By end-users, the market can be segmented into pharmaceutical and biotechnology companies, academic & research institutes, and others.


Geographically, the human platelet lysate market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.


Key Players Covered:


The major companies in the global human platelet lysate market report include Merck KGaA, Compass Biomedical, Inc., STEMCELL Technologies Inc., Regenexx, Life Science Group Ltd, Macopharma, BBI Solutions, COOK, and other prominent players.


Key Insights



  • Regulatory Scenario (Key Countries/ Region)

  • Epidemiology Overview: Key Disease Indications (Key Countries/ Regions)

  • Recent Industry Developments such as mergers, acquisitions, and partnerships


Regional Analysis:


To gain extensive insights into the market, Request for Customization


The global human platelet lysate market is expected to be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to lead the global human platelet lysate market due to the rising application of human platelet lysate in cell culture and growing research and development activities in human platelet lysate coupled with favourable support from the regulatory authorities. Europe is expected to have second-largest market share during the forecast period owing to the rising acceptance of HPL due to its various advantages and improved healthcare facilities. Asia Pacific is expected to witness growth with the highest CAGR during the forecast period due to the increasing opposition of animal-derived blood products and growing awareness about the human platelet lysate. On the other hand, Latin America and the Middle East and Africa is projected to have a lucrative growth in the human platelet lysate market in the upcoming years owing to the rising demand for advanced healthcare facilities.


Segmentation


























 ATTRIBUTE


 DETAILS

By Type




  • Heparin-based Human Platelet Lysate

  • Heparin-free Human Platelet Lysate

  • Others (Fibrinogen Depleted, etc.)



By Application




  • Research

  • Therapeutic



By End-User




  • Pharmaceutical and biotechnology companies

  • Academic & Research Institutes

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



Human Platelet Lysate Industry Developments



  • In May 2018, PL BioScience GmbH and Biogelx collaborated with an aim to enhance their current human platelet lysate based nutrient matrix and expand the range of PL Bioscience’s stem cell platform.

  • In March 2017, Biological Industries USA entered into a distribution agreement with Mill Creek Life Sciences with an aim to add PLTMax human platelet lysate to its growing stem cell portfolio.


Human Platelet Lysate Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Galemed
Johnson
Lek
Siemens Healthineers
iqvia

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X